Halozyme Therapeutics Research and Development Expenses 2010-2024 | HALO

Halozyme Therapeutics research and development expenses for the twelve months ending December 31, 2024 were $0.079B, a 3.52% increase year-over-year.

  • Halozyme Therapeutics annual research and development expenses for 2024 were $0.079B, a 3.52% increase from 2023.
  • Halozyme Therapeutics annual research and development expenses for 2023 were $0.076B, a 14.65% increase from 2022.
  • Halozyme Therapeutics annual research and development expenses for 2022 were $0.067B, a 86.72% increase from 2021.

Halozyme Therapeutics Research and Development Expenses 2010-2024 | HALO

  • Halozyme Therapeutics annual research and development expenses for 2024 were $0.079B, a 3.52% increase from 2023.
  • Halozyme Therapeutics annual research and development expenses for 2023 were $0.076B, a 14.65% increase from 2022.
  • Halozyme Therapeutics annual research and development expenses for 2022 were $0.067B, a 86.72% increase from 2021.